{"created":"2023-07-25T10:25:10.052225+00:00","id":5361,"links":{},"metadata":{"_buckets":{"deposit":"55b7c768-49d5-47c9-a557-3db37abea174"},"_deposit":{"created_by":15,"id":"5361","owners":[15],"pid":{"revision_id":0,"type":"depid","value":"5361"},"status":"published"},"_oai":{"id":"oai:air.repo.nii.ac.jp:00005361","sets":["611:939:940"]},"author_link":["14975","14971","14974","14976","14973","14972","14977"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2019-08","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"191","bibliographicPageStart":"190","bibliographicVolumeNumber":"10","bibliographic_titles":[{"bibliographic_title":"Clinical and Experimental Neuroimmunology"}]}]},"item_10001_description_6":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"This is the peer reviewed version of the following article: Kamada, S., Hanazono, A., Sanpei, Y., Inoue, T., Suzuki, S., Sugawara, M. and Iijima, K. (2019), Alternative to steroid therapy for myasthenia gravis and myositis occurring as immune-related adverse events. Clin Exp Neuroimmunol, 10: 190-191,\nwhich has been published in final form at https://doi.org/10.1111/cen3.12526. This article may be used for non-commercial purposes in accordance\nwith Wiley Terms and Conditions for Use of Self-Archived Versions.","subitem_description_type":"Other"}]},"item_10001_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.20569/00005683","subitem_identifier_reg_type":"JaLC"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"wiley"}]},"item_10001_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"info:doi/10.1111/cen3.12526","subitem_relation_type_select":"DOI"}}]},"item_10001_relation_25":{"attribute_name":"関連リンク","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1111/cen3.12526","subitem_relation_type_select":"DOI"}}]},"item_10001_rights_15":{"attribute_name":"著作権等","attribute_value_mlt":[{"subitem_rights":"wiley"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1759-1961","subitem_source_identifier_type":"ISSN"}]},"item_10001_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Kamada, Sachiko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Hanazono, Akira"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sanpei, Yui"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Inoue, Takamitsu"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Suzuki, Shigeaki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sugawara, Masashiro"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Iijima, Katsunori"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-05-26"}],"displaytype":"detail","filename":"iA_2021_1.pdf","filesize":[{"value":"171.6 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"iA_2021_1","url":"https://air.repo.nii.ac.jp/record/5361/files/iA_2021_1.pdf"},"version_id":"872cd562-eb53-4027-8650-a491d9a2d686"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Alternative to steroid therapy for myasthenia gravis and myositis occurring as immune‐related adverse events","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Alternative to steroid therapy for myasthenia gravis and myositis occurring as immune‐related adverse events"}]},"item_type_id":"10001","owner":"15","path":["940"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-05-26"},"publish_date":"2021-05-26","publish_status":"0","recid":"5361","relation_version_is_last":true,"title":["Alternative to steroid therapy for myasthenia gravis and myositis occurring as immune‐related adverse events"],"weko_creator_id":"15","weko_shared_id":-1},"updated":"2023-07-25T10:53:36.490153+00:00"}